MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2023 International Congress

    Does sex affect worsening of cognitive and IADL functions in PD with and without PD-MCI?

    I. Liepelt-Scarfone, M. Bode, S. Solbrig, K. Brockmann, W. Maetzler, I. Wurster, M. Timmers, D. Berg, S. Becker (Tübingen, Germany)

    Objective: To define how sex affects worsening of cognition and instrumental activities of daily living (IADLs) in a heterogeneous cohort of people with Parkinson’s disease…
  • 2023 International Congress

    Automatic cluster analysis using semantic relatedness for verbal fluency tasks in Parkinson’s disease

    T. Hähnel, T. Feige, J. Kunze, A. Epler, A. Frank, J. Bendig, N. Schnalke, M. Wolz, P. Themann, B. Falkenburger (Dresden, Germany)

    Objective: The aim of this work was to develop and validate a method for automated identification of semantically related clusters for verbal fluency tasks (VFT)…
  • 2023 International Congress

    Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson’s disease.The AMBITIOUS Study Protocol

    F. Colucci, M. Avenali, R. de Micco, A. Bacila, S. Cerri, G. Cuconato, V. Franco, D. Franciotta, C. Ghezzi, M. Gastaldi, C. Galandra, G. Germani, P. Mitrotti, G. Ongari, I. Palmieri, M. Picascia, A. Pichiecchio, F. Esposito, M. Cirillo, F. Di Nardo, S. Aloisio, M. Siciliano, M. Fusar Poli, M. Stanziano, B. Garavaglia, F. Cazzaniga, C. Reale, I. Tramacere, S. Priori, P. Amami, S. Piacentini, MG. Bruzzone, M. Grisoli, F. Moda, R. Eleopra, A. Tessitore, EM. Valente, R. Cilia (Milan, Italy)

    Objective: To determine in Parkinson’s disease (PD) patients carrying GBA mutation the role of Ambroxol (ABX) on the progression of cognitive performance (primary aim), motor…
  • 2023 International Congress

    APOE-ɛ4 status and cognitive decline after subthalamic nucleus-deep brain stimulation in Parkinson’s disease: preliminary results of the GENEPARK-DBS study

    A. Sánchez-Soblechero, G. Lafuente, S. Pérez, G. Velilla, M. González-Sánchez, E. González-Turiño, J. Suárez, F. Grandas, V. álvarez, B. Dela Casa (Madrid, Spain)

    Objective: The aim of this study was to evaluate wheter the presence of APOE-ε4 in a cohort of Parkinson’s disease (PD) patients treated with subthalamic…
  • 2023 International Congress

    An analysis of gender differences in the clinical profile of Parkinson’s Disease patients

    M. Nasi, N. Cazzola, L. Weis, E. Fiorenzato, V. Cianci, F. Pistonesi, A. Antonini, R. Biundo (Padova, Italy)

    Objective: The present study aimed at characterising in depth the overall clinical profile of male and females PD patients. Background: Parkinson Disease (PD) is the…
  • 2023 International Congress

    Increased MD and decreased FA reflect cognitive impairment in PSP

    S. Kannenberg, AC. Hausmann, A. Schnitzler, CJ. Hartmann, C. Rubbert, J. Caspers (Düsseldorf, Germany)

    Objective: To identify white matter (WM) alterations associated with cognitive impairment in progressive supranuclear palsy (PSP). Background: PSP is accompanied with cognitive impairment [1;2], but…
  • 2023 International Congress

    Cognitive underside of Parkinson’s Disease: A working memory updating failure in freezing of gait

    M. Mandal, A. Khan (PUNE, India)

    Objective: To investigate the role of components of working memory updating in freezing of gait phenomenon Parkinson’s Disease Background: The role of cognitive deficits has…
  • 2023 International Congress

    The impact of mild cognitive impairment on functioning in people with Parkinson’s disease

    J. Petrillo, TM. Brown, K. Paumier, J. Dine, R. Sawant, S. Baradaran, A. Koenig (Cambridge, USA)

    Objective: To understand the experience of mild cognitive impairment (MCI) in people with Parkinson’s disease (PwP) and its impact on daily life. Background: Parkinson’s disease…
  • 2023 International Congress

    Nucleus basalis of Meynert and total gray matter atrophy are related to cognitive and gait decline in Parkinson’s disease

    A. Yeung, F. Ba, M. Gee, R. Camicioli (Edmonton, Canada)

    Objective: To assess the associations between the nucleus basalis of Meynert (NBM) and total grey matter atrophy with cognitive phenotype and gait measures in a…
  • 2023 International Congress

    Narrative review of the efficacy of the efficacy of transcranial magnetic stimulation with patients with Parkinson disease.

    A. Elaraby, M. Shaien (Gizah, Egypt)

    Objective: To evaluate the efficacy of transcranial magnetic stimulation with patients with Parkinson diseases. Background: Parkinson's disease is one of the most common causes of…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley